STOCK-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Options

A summary of the status of the stock options under the 2014 Plan as of December 31, 2024, and changes during the year is presented below:

	Number of Shares	Weighted- Average  Exercise Price		Weighted-Average  Remaining  Contractual Term  (In Years)	Aggregate Intrinsic Value
Balance - December 31, 2023	322,405	$	7.30	5.3	$	1,539
Granted	—	—
Exercised	(44,473)	4.75
Forfeited	—	—
Expired	(21,243)	16.77
Balance - December 31, 2024	256,689	$	6.96	4.4	$	415

The following tables summarizes the Company’s RSA activity under the 2021 Plan during the year ended December 31, 2024:

	Stock Options						Restricted Stock Units
	Number of Options	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value		Shares	Weighted- Average Grant Date Fair Value
Balance - December 31, 2023	13,865	$	261.25	7.5	$	—	278,290	$	34.05
Granted	—	—					181,270	15.75
Exercised / Vested	—	—					(164,944)	32.93
Forfeited	—	—					(29,804)	28.67
Balance - December 31, 2024	13,865	$	261.25	6.5	$	—	264,812	$	22.83

Schedule of RSUs

The following tables summarizes the Company’s RSA activity under the 2021 Plan during the year ended December 31, 2024:

	Stock Options						Restricted Stock Units
	Number of Options	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value		Shares	Weighted- Average Grant Date Fair Value
Balance - December 31, 2023	13,865	$	261.25	7.5	$	—	278,290	$	34.05
Granted	—	—					181,270	15.75
Exercised / Vested	—	—					(164,944)	32.93
Forfeited	—	—					(29,804)	28.67
Balance - December 31, 2024	13,865	$	261.25	6.5	$	—	264,812	$	22.83